Our products

Approved for use in Canada

Patients and healthcare providers in Canada, view the PDF to learn more.

image
my-path

MyPATH, argenx's Patient Support Program is committed to supporting people throughout their treatment journey. At the MyPATH Patient Support Program, we understand that living with a chronic condition like generalized Myasthenia Gravis (gMG) is different for everyone. That’s why we’re dedicated to supporting patients at every step – in the way that suits them best. 

If you have been enrolled in the MyPATH Program, visit the MyPATH website to learn more about how MyPATH can support you along your treatment journey, including connecting you with a Nurse Case Manager, navigating insurance coverage, helping you understand your treatment, coordinating the treatment, and continuing to provide ongoing support

Note: the MyPATH site is intended for patients who are enrolled in the MyPATH Patient Support Program, and requires a Drug Identification Number to access.